logo
Eek, It's a Woolly Mouse! The First Step in Reviving a Prehistoric Mammoth Starts with Adorable Rodent (Exclusive)

Eek, It's a Woolly Mouse! The First Step in Reviving a Prehistoric Mammoth Starts with Adorable Rodent (Exclusive)

Yahoo04-03-2025
Scientists at the Dallas-based Colossal Biosciences have taken a big step towards their goal of bringing back the woolly mammoth by creating what they've dubbed Colossal Woolly Mouse
"I'm excited," Beth Shapiro, Chief Science Officer at Colossal, tells PEOPLE of the new mice, which have been genetically modified to have woolly mammoth traits
'In the next six months, we'll see if our woolly mice are actually happier in cooler environments, which is the predicted effects of these changes,' she adds
Behold, the woolly mouse.
Scientists at the Dallas-based Colossal Biosciences have taken a small step towards their goal of bringing back the woolly mammoth: Colossal Woolly Mouse.
"I'm excited," Beth Shapiro, Chief Science Officer at Colossal, tells PEOPLE, explaining that this is "really our first validation" that they actually can create living animals that have been genetically modified to have woolly mammoth traits.
"It's the first time that we've succeeded," she adds.
Like woolly mammoths, these mice have curlier hair — which is the same color of the mammoth mummies found in the permafrost — as well as a gene that should impact the way their bodies metabolize fat.
To be clear, there was not a prehistoric, or even historic woolly mouse. But, in order for the scientists to prove they were on the right track in the quickest possible time, they chose to perform the experiment with mice rather than actual elephants — which are the closest living relative to the woolly mammoth.
'Elephants have a 22-month gestation and then it takes another decade to reach sexual maturity," explains Shapiro, who pointed out that that's a "long time" to wait to see if their experiment would in fact lead to elephants having a woolly coat.
'It doesn't make any sense," she adds. But since mice only have a 20-day gestation, that made them a more ideal choice.
A unique feature of the mammoth are clumps on their back filled with fat to help keep the animal both insulated and energized during long, frigid months in largely barren landscapes.
The Colossal woolly mouse is the first living animal engineered to express multiple cold-adapted traits using mammoth gene orthologs (genes in different species that evolved from a common ancestral gene and normally retain the same function). As such, they represent a living model for studying cold-climate adaptations in mammals.
'In the next six months, we'll see if our woolly mice are actually happier in cooler environments, which is the predicted effects of these changes,' Shapiro says.
According to Colossal, their efforts — which ideally will result in creating a hybrid species that's virtually genetically indistinguishable from woolly mammoths — could also lead to breakthroughs in the fight against elephant endotheliotropic herpesviruses. EEHV is a highly-dangerous and fatal condition that wreaks havoc in young Asian elephants.
In addition to the mammoth, Colossal is working on two other "de-extinction" projects: bringing back the Dodo and the Thylacine, or Tasmanian tiger.
Along with Shapiro, Anna Keyte, who is leading the Dodo efforts, and Sara Ord, who is heading the Thylacine project, say it's difficult to explain to their families exactly what they do for a living. But they try to put it into terms that allow people to understand this is more than just making a real-life Jurassic Park or creating a new exotic pet.
Right now, Keyte is thinking a lot about the implications of bird flu, which has taken out some recovering populations of birds.
'It has been really bad for California condors, so one of the things we think about in our de-extinction pipeline is not only bringing back species we've lost, but making them resilient to the challenges of today,' she tells PEOPLE.
Ord notes that there is also perhaps a moral or ethical angle to bringing back species that were killed off through human interference.
The Thylacine, a carnivorous marsupial, was aggressively hunted to extinction in the course of about 100 years. The Australian government signed a species protection act in July 1936, but just two months later the last animal, commonly known as the Tasmanian tiger, died.
'It's an example of a human caused extinction," says Ord. "And so how responsible are we to bring back this species that we drove away?"
Related: One of the 'World's Rarest' Fish, Thought to Be Extinct, Rediscovered After 85 Years
The team leaders of the three de-extinction projects are all women, something you would not have seen in the scientific world even a few years ago.
Women have been underrepresented in STEM (science, technology, engineering and mathematics) for many years. Women remain underrepresented in STEM occupations, with two-thirds (65%) men and about one-third (35%) women. Between 2011 and 2021, the number of women in the STEM workforce increased 31%, from 9.4 million to 12.3 million. (National Science Foundation, 2022)
Shapiro tells PEOPLE she's been watching the proportion of women in the system grow.
'It brings a different set of viewpoints that we really need,' she says. 'We're trying to solve some of the hardest problems in biology. It is going to take that sort of diversity of experience, diversity of viewpoints. It's not just the technology that's going to make that happen.'
As for the woolly mice, where do they go from here?
'This is not a project that will go on indefinitely. It served a purpose of testing genotype to phenotype, which we got positive results,' says Ord.
But do not fear for the living mice, because there are plenty of takers once their work is done.
'The CEO Ben Lamm made the comment 'Don't let Sara know because she's going to be adopting all of them,' ' Ord says with a laugh. 'We all are not only passionate about the science, but passionate about the animals. And that holds all the way to the wooly mouse.'
Read the original article on People
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

Yahoo

timean hour ago

  • Yahoo

VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer

Veteran commercial leader to scale AI-enabled NAMkind™ liver and intestine toxicology services in a rapidly growing market SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the 'Company' or 'VivoSim Labs'), a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional ('3D') human tissue models of liver and intestine, announced today that it has appointed Tony Lialin as its Chief Commercial Officer. Mr. Lialin brings more than two decades of experience turning breakthrough life science platforms into scalable, predictable revenue. He has built commercial teams from the ground up, forged strategic pharma partnerships, and helped scale multiple businesses that were later acquired by leading industry players. At VivoSim Labs, he will lead go-to-market strategy, partnerships, and the expansion of the Company's San Diego-based services that combine organ-specific 3D models with AI-driven analytics to deliver decision-ready insights earlier in development. Market Opportunity: According to an internal analysis conducted by VivoSim Labs in July 2025, the global combined liver and gastrointestinal in-vitro models and toxicology services market generated $641M in revenue in 2024. Services represented 53.1% of revenue vs. models at 46.9% of revenue. The United States accounted for $325M (50.8%) of the global market for liver toxicology models and services. Adoption of 3D human-relevant systems is rising, with the global in vitro liver model market growing at 5.9% CAGR from 2020 to 2024. Category Tailwinds: Biopharma sponsors are accelerating the use of non-animal new approach methodologies (NAMs). Regulatory momentum, including the FDA Modernization Act 2.0 (2022), supports validated alternatives and is catalyzing broader adoption of human-relevant in vitro models for ADME and toxicology. How AI Helps: VivoSim Labs applies AI to quantify multi-parametric toxicity signatures across liver and intestinal organoid assays. By improving signal-to-noise in dose-response analyses, the platform helps project teams prioritize candidates and plan studies with greater confidence. 'VivoSim Labs sits at the intersection of biology and AI. Our NAMkind™ models are designed to answer make-or-break questions earlier,' said Tony Lialin, Chief Commercial Officer, VivoSim Labs. 'We will scale a high-touch, consultative service from our San Diego lab so pharma and biopharma teams get decision-ready toxicology insights that aim to streamline pre-IND decision-making and reduce late-stage surprises.' 'Tony has a rare track record of turning disruptive science into durable commercial engines,' said Keith Murphy, Executive Chairman, VivoSim Labs. 'As sponsors move rapidly to 3D, human-relevant models, they want a partner—not just a plate or a protocol—to guide critical decisions. Tony knows how to build the solutions that our customers need.' About VivoSim Labs VivoSim Labs, Inc. ("VivoSim" and the 'Company'), is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional ('3D') human tissue models of liver and intestine. The Company offers partners liver and intestinal toxicology insights using its new approach methodologies ("NAM") models. The Company anticipates accelerated adoption of human tissue models following the U.S. Food and Drug Administration ('FDA") announcement on April 10, 2025 to refine animal testing requirements in favor of these non-animal NAM methods. VivoSim Labs operates from San Diego, CA. Visit Forward-Looking Statements Any statements contained in this press release that do not describe historical facts constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations but are subject to a number of risks and uncertainties. Forward-looking statements include statements regarding expansion of the Company's San Diego-based services; the potential for the Company's organ-specific 3D models and AI-driven analytics to deliver decision-ready insights earlier in development; the market opportunity and market size of gastrointestinal in-vitro models and toxicology services; and the ability of the Company's services to improve signal-to-noise in dose-response calls or help project teams prioritize candidates and studies with greater confidence. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. These risks and uncertainties and other factors are identified and described in more detail in the Company's filings with the SEC, including its Annual Report on Form 10-K filed with the SEC on June 5, 2025, as such risk factors are updated in its most recently filed Quarterly Report on Form 10-Q filed with the SEC on August 12, 2025. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that the Company may issue in the future. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events, or circumstances or to reflect the occurrence of unanticipated events. ContactInvestor Relationsinfo@ Labs, in to access your portfolio

Scientists tout potential weight loss advance using gene technology
Scientists tout potential weight loss advance using gene technology

Yahoo

timea day ago

  • Yahoo

Scientists tout potential weight loss advance using gene technology

There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain microproteins that store fat. In findings published in the Proceedings of the National Academy of Sciences (PNAS) in the US, the team from the California-based Salk Institute for Biological Studies said that the microproteins "could potentially serve as drug targets to treat obesity and other metabolic disorders." The findings could prove particularly useful for people who struggle with other treatments such as lifestyle changes, bariatric surgery or courses of drugs such as Ozempic and Wegovy. "The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide," the Salk Institute warned, reminding that being overweight is linked to "other metabolic disorders" such as diabetes, cardiovascular diseases, chronic kidney disease, and cancers. Microproteins, according to the team, are "an understudied class of molecules found throughout the body that play roles in both health and disease." The team believes the findings are noteworthy because they entailed the use of CRISPR gene editing to screen thousands of fat cell genes to try to find genes "that likely code for microproteins that regulate either fat cell proliferation or lipid accumulation." "We wanted to know if there was anything we had been missing in all these years of research into the body's metabolic processes," says Salk's Victor Pai. Solve the daily Crossword

Invasive ticks have scientists spooked about new diseases
Invasive ticks have scientists spooked about new diseases

National Geographic

timea day ago

  • National Geographic

Invasive ticks have scientists spooked about new diseases

Over 100 new tick species have entered the U.S. in the last 50 years. Scientists say it's just the beginning. Two Asian longhorned ticks sit on an open palm. On the left is an adult female, and on the right is a nymph. The longhorned tick is from East Asia, but since entering the U.S., has introduced a diseases dangerous to cattle. Photograph by Lauren Bishop/CDC / Science Source Between 2019 and 2023, seven ticks not native to the United States entered Connecticut, according to a new study published in the journal iScience. They came from a variety of countries as far away as Germany, Guatemala, Tanzania, Brazil, Scotland, and Poland. While the study didn't find evidence of these invasive ticks bringing new diseases to the U.S., experts say they could one day soon. Meanwhile, the study does suggest they could drive a rise in tick-related diseases already seen in the U.S., as they found these ticks can carry pathogens similar to those carried by native ticks. Two invasive tick species from Central America tested positive for a bacteria similar to Rocky Mountain spotted fever, a disease that can cause fever, vomiting, muscle pain, and even death if untreated. It's part of an alarming trend: cases of tick-borne disease in the U.S. jumped from about 23,000 in 2004 to around 71,000 cases in 2022. 'Prior to 2018, here in the northeastern U.S… we didn't have cases of Rocky Mountain spotted fever. But since 2018, we are seeing a number of up to ten cases of Rocky Mountain spotted fever in [Connecticut]. And we have had mortalities as a result,' says Yale University epidemiologist Goudarz Molaei, co-author of the new study. Experts say identifying all the ways ticks can spread and carry diseases is critical to reducing the number of people who become seriously ill after being bitten. Their spread is a concern—during the last 50 years, over 140 non-native tick species have been brought into the U.S., hitching a ride on livestock, exotic pets, or people. At the same time, climate change has expanded the habitat ticks can live in. If more invasive ticks establish U.S. populations, 'it is just a matter of time that these invasive ticks will either pick up local pathogens or native pathogens that circulate in the U.S., or they start carrying the pathogens that they transmit in their native range,' says Molaei. How ticks spread diseases Ticks pick up diseases after biting animal hosts like deer. They can then transmit disease to humans by biting us. The U.S. is home to around 50 native tick species that bite people. Those bites can result in illnesses such as Lyme disease, anaplasmosis, babesiosis, and Rocky Mountain spotted fever. (Learn more about how a warming climate is helping ticks reach new places.) A crowdsourced and laboratory-validated tick map shows some species moving northward in recent years. 'We are seeing the increasing prevalence of pathogens in new counties, in new areas, that we never saw in 2019,' says Saravanan Thangamani, SUNY Upstate Medical University microbiologist whose research team created the tick map. Molaei hypothesizes that not all these reported cases are 'true' Rocky Mountain spotted fever, but instead a similar illness caused by the closely related bacterium R. amblyommatis—the same species the invasive ticks in the study are carrying. 'We have evidence that this bacterium is being carried by not only these invasive ticks coming from South and Central America, [but] some local ticks,' says Molaei. The most successful invasive tick to enter the U.S. is the Asian longhorned tick, a relatively recent arrival that was first documented feeding on a sheep in New Jersey in 2017. Native to East Asia and now found in Australia, New Zealand, and the Pacific Islands, this tick has since spread to at least 21 U.S. states and Washington D.C. and carries pathogens responsible for various diseases that native U.S. ticks carry. But a tick testing positive for a pathogen doesn't necessarily mean it's capable of transmitting that pathogen to humans, says Molaei. 'Investigations are ongoing to find out exactly to what extent [the Asian longhorned tick] bites humans, and what disease agents this tick will transmit,' says Molaei. 'Some of the early fears [about longhorned ticks] have not seemed to come to be realized,' Bryon Backenson, director of the Bureau of Communicable Disease Control at the New York State Department of Health. He adds that disease spread depends on ticks finding the right host and conditions: 'Finding a pathogen in the tick is different from whether or not the tick can actually transmit it.' New diseases in animals, but not humans (yet) 'To my knowledge there has not been a human clinical case acquired in the U.S. from an introduced tick,' says Risa Pesapane, Ohio State University disease ecologist. However, the longhorned tick did bring a non-native parasite called Theileria orientalis that can cause bovine theileriosis in cattle, says Pesapane, now widespread and dangerous for livestock health. And invasive ticks that arrived in Florida through the reptile pet trade now feed on native reptiles, adds Pesapane. And climate change is predicted to create a hospitable environment for some warm-weather ticks that may not have been able to survive in a U.S. climate before, allowing tick populations to move farther north. 'One degree is a lot for [ticks]. One degree allows them to move way further north than they would otherwise,' says Backenson. Climate change also means shorter winters, so both ticks and humans are active for more of the year. 'We are seeing longer seasons where more ticks are active… and this generally means there are more days of the year where people are out wearing shorts and sandals and potentially encountering ticks,' says Pesapane. One dangerous virus Thangamani points to is tick-borne encephalitis, which ticks carry in Europe and Asia and can be fatal. Although very few cases have been reported in travelers returning to the U.S., Thangamani claims if those ticks and pathogens were to establish themselves in the U.S., it would be a major threat to human health. 'Ticks are very resilient,' says Thangamani, adding that after feeding, a female tick can lay thousands of eggs. 'All you need is one tick to establish a population in an area.' Preventing tick-borne disease While it's unclear how risky invasive tick species are, it is something scientists are monitoring, says Hannah Tiffin, entomologist at the University of Kentucky. 'It's something that we could do a better job with,' Tiffin says, suggesting better coordination among public health officials and scientists to identify ticks and pathogens before they spread. Thangamani recommends using the tick map to see where you might be most at risk of getting a tick bite. His research team is also encouraging health care providers to refer to the map, so doctors can take it into account when treating patients with tick bites. (Ticks are taking over city parks. Here's how to avoid them.) Travelers should let their doctors know of recent travel if receiving treatment for a tick bite, since some invasive and native ticks look similar, says Tiffin; without knowing a patient's recent travel history, it's easy to visually misidentify a tick species. If hiking near home or abroad, wear protective clothes, use insect repellent, and stay away from tick-infested areas. Before returning to the U.S., Thangamani recommends travelers diligently check their bodies, clothes, and luggage. He adds: 'It is very easy to introduce a new species without us knowing it's happening.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store